Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

NCT03590730 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.

NCT NCT03590730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03590730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
Lead sponsor
Keimyung University Dongsan Medical Center
Phase
Observational
Overall status
Terminated
Start date
November 15, 2017
Completion date
July 15, 2021
Enrollment
12 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

implantable cardioverter defibrillator, primary prevention, sudden cardiac death, valvular heart disease